Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá

159 Páginas.

Autores:
Salazar Ponce, Rosa Elena
Murcia Pinilla, Lina María
De la Cruz Nocera, Giovanni
Tipo de recurso:
Fecha de publicación:
2011
Institución:
Universidad de la Sabana
Repositorio:
Repositorio Universidad de la Sabana
Idioma:
spa
OAI Identifier:
oai:intellectum.unisabana.edu.co:10818/3418
Acceso en línea:
http://hdl.handle.net/10818/3418
Palabra clave:
Lupus eritematoso sistémico-Investigaciones
Lupus eritematoso sistémico-Epidemiología-Investigaciones
Lupus eritematoso sistémico-Patología-Investigaciones
Lupus eritematoso sistémico-Clases sociales-Investigaciones
Rights
License
http://purl.org/coar/access_right/c_abf2
id REPOUSABA2_6ccf0c10bba4f2ccde3646201ebcfbe0
oai_identifier_str oai:intellectum.unisabana.edu.co:10818/3418
network_acronym_str REPOUSABA2
network_name_str Repositorio Universidad de la Sabana
repository_id_str
dc.title.es_CO.fl_str_mv Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá
title Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá
spellingShingle Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá
Lupus eritematoso sistémico-Investigaciones
Lupus eritematoso sistémico-Epidemiología-Investigaciones
Lupus eritematoso sistémico-Patología-Investigaciones
Lupus eritematoso sistémico-Clases sociales-Investigaciones
title_short Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá
title_full Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá
title_fullStr Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá
title_full_unstemmed Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá
title_sort Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá
dc.creator.fl_str_mv Salazar Ponce, Rosa Elena
Murcia Pinilla, Lina María
De la Cruz Nocera, Giovanni
dc.contributor.advisor.none.fl_str_mv Londoño Patiño, John Darío
Ovalle Oñate, Rafael
De Zubiría, Alberto
Bello Gualtero, Juan Manuel
Jaimes Fernández, Diego Alejandro
dc.contributor.author.none.fl_str_mv Salazar Ponce, Rosa Elena
Murcia Pinilla, Lina María
De la Cruz Nocera, Giovanni
dc.subject.es_CO.fl_str_mv Lupus eritematoso sistémico-Investigaciones
Lupus eritematoso sistémico-Epidemiología-Investigaciones
Lupus eritematoso sistémico-Patología-Investigaciones
Lupus eritematoso sistémico-Clases sociales-Investigaciones
topic Lupus eritematoso sistémico-Investigaciones
Lupus eritematoso sistémico-Epidemiología-Investigaciones
Lupus eritematoso sistémico-Patología-Investigaciones
Lupus eritematoso sistémico-Clases sociales-Investigaciones
description 159 Páginas.
publishDate 2011
dc.date.created.none.fl_str_mv 2011
dc.date.accessioned.none.fl_str_mv 2012-08-15T17:24:25Z
dc.date.available.none.fl_str_mv 2012-08-15T17:24:25Z
dc.date.issued.none.fl_str_mv 2012-08-15
dc.type.none.fl_str_mv bachelorThesis
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.local.none.fl_str_mv Tesis de especialización
dc.type.hasVersion.none.fl_str_mv publishedVersion
dc.identifier.citation.none.fl_str_mv Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010; 39:257-68.
Tikly M, Navarra SV. Lupus in the developing world is it any different? Best Pract Res Clin Rheumatol. 2008; 22:643-55.
Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008; 358:929- 39.
Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002; 16:847-58.
McCarty DJ, Manzi S, Medsger TA, Jr., Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995; 38:1260-70.
McAlindon T. Update on the epidemiology of systemic lupus erythematosus: new spins on old ideas. Curr Opin Rheumatol. 2000; 12:104-12.
Simard JF, Costenbader KH. What can epidemiology tell us about systemic lupus erythematosus? Int J Clin Pract. 2007; 61:1170-80.
Jimenez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003; 25:3-12.
Isenberg D, Bacon P, Bombardier C, Gladman D, Goldsmith CH, Kalunian K, et al. Criteria for assessing disease activity in systemic lupus erythematosus. J Rheumatol. 1989;16:1395-6
Chang E, Abrahamowicz M, Ferland D, Fortin PR. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians. J Clin Epidemiol. 2002; 55:488- 97.
Gladman D, Urowitz M, Kagal A, Hallet D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheum. 2000; 27:377-9.
Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005; 19:685-708.
Yee CS, McElhone K, Teh LS, Gordon C. Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects. Best Pract Res Clin Rheumatol. 2009; 23:457-67.
Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010; 69:1269-74.
Alarcon GS, Calvo-Alen J, McGwin G, Jr., Uribe AG, Toloza SM, Roseman JM, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006; 65:1168-74.
Fernandez M, Calvo-Alen J, Alarcon GS, Roseman JM, Bastian HM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. Arthritis Rheum. 2005; 52:1655-64.
Gordon C, Sutcliffe N, Skan J, Stoll T, Isenberg DA. Definition and treatment of lupus flares measured by the BILAG index. Rheumatology. 2003; 42:1372-9.
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35:630-40.
. Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Bombardieri S. Disease activity in systemic lupus erythematosus: report of the Consen- sus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol. 1992; 10:549-54.
Gladman D, Ibanez D, Urowitz M. Systemic lupus erythematosus activity index 2000. J Rheumatol. 2002; 29:288-91.
Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989; 32:1107-18.
Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996; 39:363-9.
Gladman DD, Urowitz MB. The SLICC/ACR damage index: progress report and experience in the field. Lupus. 1999; 8:632-7.
Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus. 2001; 10:93-96.
. Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response.Qual Life Res. 2001; 10:405-13
Almehed K, Carlsten H, Forsblad-d'Elia H. Health-related quality of life in systemic lupus erythematosus and its association with disease and work disability. Scand J Rheumatol. 2010; 39:58-62.
Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine (Baltimore). 2004; 83:1-17.
Alarcón GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus. 1999; 8:197-209.
Isenberg DA, Allen E, Farewell V, D'Cruz D, Alarcón GS, Aranow C, et al. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis. 2011; 70:54-9.
Pope J. The revised BILAG Index with numerical scoring in systemic lupus erythematosus: added value with some limitations.Rheumatology (Oxford). 2010; 49:1616-7.
Yee CS, Cresswell L, Farewell V, Rahman A, Teh LS, Griffiths B, et al. Numerical scoring for the BILAG-2004 index. Rheumatology (Oxford). 2010; 49:1665-9
Furie RA, Petri MA, Wallace DJ, Ginzler EM, Merrill JT, Stohl W, et al. Novel evidencebased systemic lupus erythematosus responder index. Arthritis Rheum. 2009; 61:1143- 51.
Petri M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am. 2005; 31:245-54
Ruiz O, Londoño J; Velez P; Ortiz I; Motta L; Valle-Oñate R. Descripcion de una cohorte de pacientes con Lupus Eritematoso Sistemico (LES) en un Hospital de BogotaColombia. Rev Colomb Rumatol. 2003; 10:266-76.
Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore). 1996; 75:124-30.
Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002; 61:1065-70
Garcia MA, Marcos JC, Marcos AI, Pons-Estel BA, Wojdyla D, Arturi A, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus. 2005; 14:938-46
Pinto L VC, Márquez Y. Subgrupos de Lupus Eritematoso Sistémico: influencia de la edad de inicio, la raza, el sexo y el perfil de anticuerpos en las manifestaciones clínicas de la enfermedad. Rev Col Reumatol. 2008; 15:291-8
Hsu CY, Pu C, Sewell KL. Systemic lupus erythematosus as a cause of failure to thrive in older people. J Am Geriatr Soc.1996; 44:337-8.
Schiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, Lanzoni VP, Ferraz ML, Silva AE. Late-onset systemic lupus erythematosus-associated liver disease. Rheumatol Int. 2010 Apr 8. [Epub ahead of print]
Koh ET, Boey ML. Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol. 1994; 21:1463-7.
González LA, Ramírez LA. Lupus eritematoso sistémico de inicio tardío. Rev Colomb Reumatol. 2008; 15:168-85.
Gaviria L, Rodelo J , Uribe O , Vásquez G, Ramírez L Características clínicas y serológicas de los pacientes con LES de inicio tardío en una población colombiana. Rev Colomb Reumatol. 2007; 14: 23-31
Baer AN, Maynard JW, Shaikh F, Magder LS, Petri M. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol. 2010; 37:1143-9.
Toloza SM, Jolly M, Alarcón GS. Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010; 12:237-49
Drenkard C, Alarcon-Segovia D. The new prognosis of systemic lupus erythematosus: treatment-free remission and decreased mortality and morbidity. Isr Med Assoc J. 2000; 2:382-7.
Duran S, Gonzalez LA, Alarcon GS. Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus erythematosus: lessons from LUMINA, a multiethnic US cohort. J Clin Rheumatol. 2007; 13:350-3
Lalani S, Pope J, de Leon F, Peschken C; Members of CaNIOS/1000 Faces of Lupus. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumatol. 2010 ;37:38-44
Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA. Analysis of the relationship between the disease activity and damage in patients with systemic lupus erythematosus a 5 year prospective study. Rheumatology. 2004; 43:1039-44
Stoll T, Seifert B, Isenberg D. ACR/SLICC damage index is a useful predictor of severe outcome in SLE patients and an indicator of morbidity in different ethnic groups. Brit J Rheumatol. 1996; 35:248-54.
Chambers SA, Allen E, Rahman A, Isenberg D. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford). 2009; 48:673-5
Alarcón GS, Roseman JM, McGwin G Jr, Uribe A, Bastian HM, Fessler BJ, Baethge BA, Friedman AW, Reveille JD; LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage Rheumatology (Oxford). 2004; 43:202-5.
Gilboe IM, Kvien TK, Husby G. Disease course in systemic lupus erythematosus: changes in health status, disease activity, J Rheumatol. 2001; 28:266-74
Yazdany J, Yelin E. Health-Related Quality of Life and Employment Among Persons with Systemic Lupus Erythematosus . Rheum Dis Clin North Am. 2010; 36: 15–32.
Alarcón GS, McGwin G Jr, Uribe A, Friedman AW, Roseman JM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004; 51:465-74.
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10818/3418
dc.identifier.local.none.fl_str_mv 152672
TE00273
identifier_str_mv Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010; 39:257-68.
Tikly M, Navarra SV. Lupus in the developing world is it any different? Best Pract Res Clin Rheumatol. 2008; 22:643-55.
Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008; 358:929- 39.
Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002; 16:847-58.
McCarty DJ, Manzi S, Medsger TA, Jr., Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995; 38:1260-70.
McAlindon T. Update on the epidemiology of systemic lupus erythematosus: new spins on old ideas. Curr Opin Rheumatol. 2000; 12:104-12.
Simard JF, Costenbader KH. What can epidemiology tell us about systemic lupus erythematosus? Int J Clin Pract. 2007; 61:1170-80.
Jimenez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003; 25:3-12.
Isenberg D, Bacon P, Bombardier C, Gladman D, Goldsmith CH, Kalunian K, et al. Criteria for assessing disease activity in systemic lupus erythematosus. J Rheumatol. 1989;16:1395-6
Chang E, Abrahamowicz M, Ferland D, Fortin PR. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians. J Clin Epidemiol. 2002; 55:488- 97.
Gladman D, Urowitz M, Kagal A, Hallet D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheum. 2000; 27:377-9.
Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005; 19:685-708.
Yee CS, McElhone K, Teh LS, Gordon C. Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects. Best Pract Res Clin Rheumatol. 2009; 23:457-67.
Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010; 69:1269-74.
Alarcon GS, Calvo-Alen J, McGwin G, Jr., Uribe AG, Toloza SM, Roseman JM, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006; 65:1168-74.
Fernandez M, Calvo-Alen J, Alarcon GS, Roseman JM, Bastian HM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. Arthritis Rheum. 2005; 52:1655-64.
Gordon C, Sutcliffe N, Skan J, Stoll T, Isenberg DA. Definition and treatment of lupus flares measured by the BILAG index. Rheumatology. 2003; 42:1372-9.
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35:630-40.
. Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Bombardieri S. Disease activity in systemic lupus erythematosus: report of the Consen- sus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol. 1992; 10:549-54.
Gladman D, Ibanez D, Urowitz M. Systemic lupus erythematosus activity index 2000. J Rheumatol. 2002; 29:288-91.
Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989; 32:1107-18.
Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996; 39:363-9.
Gladman DD, Urowitz MB. The SLICC/ACR damage index: progress report and experience in the field. Lupus. 1999; 8:632-7.
Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus. 2001; 10:93-96.
. Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response.Qual Life Res. 2001; 10:405-13
Almehed K, Carlsten H, Forsblad-d'Elia H. Health-related quality of life in systemic lupus erythematosus and its association with disease and work disability. Scand J Rheumatol. 2010; 39:58-62.
Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine (Baltimore). 2004; 83:1-17.
Alarcón GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus. 1999; 8:197-209.
Isenberg DA, Allen E, Farewell V, D'Cruz D, Alarcón GS, Aranow C, et al. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis. 2011; 70:54-9.
Pope J. The revised BILAG Index with numerical scoring in systemic lupus erythematosus: added value with some limitations.Rheumatology (Oxford). 2010; 49:1616-7.
Yee CS, Cresswell L, Farewell V, Rahman A, Teh LS, Griffiths B, et al. Numerical scoring for the BILAG-2004 index. Rheumatology (Oxford). 2010; 49:1665-9
Furie RA, Petri MA, Wallace DJ, Ginzler EM, Merrill JT, Stohl W, et al. Novel evidencebased systemic lupus erythematosus responder index. Arthritis Rheum. 2009; 61:1143- 51.
Petri M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am. 2005; 31:245-54
Ruiz O, Londoño J; Velez P; Ortiz I; Motta L; Valle-Oñate R. Descripcion de una cohorte de pacientes con Lupus Eritematoso Sistemico (LES) en un Hospital de BogotaColombia. Rev Colomb Rumatol. 2003; 10:266-76.
Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore). 1996; 75:124-30.
Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002; 61:1065-70
Garcia MA, Marcos JC, Marcos AI, Pons-Estel BA, Wojdyla D, Arturi A, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus. 2005; 14:938-46
Pinto L VC, Márquez Y. Subgrupos de Lupus Eritematoso Sistémico: influencia de la edad de inicio, la raza, el sexo y el perfil de anticuerpos en las manifestaciones clínicas de la enfermedad. Rev Col Reumatol. 2008; 15:291-8
Hsu CY, Pu C, Sewell KL. Systemic lupus erythematosus as a cause of failure to thrive in older people. J Am Geriatr Soc.1996; 44:337-8.
Schiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, Lanzoni VP, Ferraz ML, Silva AE. Late-onset systemic lupus erythematosus-associated liver disease. Rheumatol Int. 2010 Apr 8. [Epub ahead of print]
Koh ET, Boey ML. Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol. 1994; 21:1463-7.
González LA, Ramírez LA. Lupus eritematoso sistémico de inicio tardío. Rev Colomb Reumatol. 2008; 15:168-85.
Gaviria L, Rodelo J , Uribe O , Vásquez G, Ramírez L Características clínicas y serológicas de los pacientes con LES de inicio tardío en una población colombiana. Rev Colomb Reumatol. 2007; 14: 23-31
Baer AN, Maynard JW, Shaikh F, Magder LS, Petri M. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol. 2010; 37:1143-9.
Toloza SM, Jolly M, Alarcón GS. Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010; 12:237-49
Drenkard C, Alarcon-Segovia D. The new prognosis of systemic lupus erythematosus: treatment-free remission and decreased mortality and morbidity. Isr Med Assoc J. 2000; 2:382-7.
Duran S, Gonzalez LA, Alarcon GS. Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus erythematosus: lessons from LUMINA, a multiethnic US cohort. J Clin Rheumatol. 2007; 13:350-3
Lalani S, Pope J, de Leon F, Peschken C; Members of CaNIOS/1000 Faces of Lupus. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumatol. 2010 ;37:38-44
Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA. Analysis of the relationship between the disease activity and damage in patients with systemic lupus erythematosus a 5 year prospective study. Rheumatology. 2004; 43:1039-44
Stoll T, Seifert B, Isenberg D. ACR/SLICC damage index is a useful predictor of severe outcome in SLE patients and an indicator of morbidity in different ethnic groups. Brit J Rheumatol. 1996; 35:248-54.
Chambers SA, Allen E, Rahman A, Isenberg D. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford). 2009; 48:673-5
Alarcón GS, Roseman JM, McGwin G Jr, Uribe A, Bastian HM, Fessler BJ, Baethge BA, Friedman AW, Reveille JD; LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage Rheumatology (Oxford). 2004; 43:202-5.
Gilboe IM, Kvien TK, Husby G. Disease course in systemic lupus erythematosus: changes in health status, disease activity, J Rheumatol. 2001; 28:266-74
Yazdany J, Yelin E. Health-Related Quality of Life and Employment Among Persons with Systemic Lupus Erythematosus . Rheum Dis Clin North Am. 2010; 36: 15–32.
Alarcón GS, McGwin G Jr, Uribe A, Friedman AW, Roseman JM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004; 51:465-74.
152672
TE00273
url http://hdl.handle.net/10818/3418
dc.language.iso.es_CO.fl_str_mv spa
language spa
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv http://purl.org/coar/access_right/c_abf2
dc.publisher.none.fl_str_mv Universidad de La Sabana
dc.publisher.program.none.fl_str_mv Especialización en Medicina Interna
dc.publisher.department.none.fl_str_mv Facultad de Medicina
publisher.none.fl_str_mv Universidad de La Sabana
dc.source.none.fl_str_mv Universidad de La Sabana
Intellectum Repositorio Universidad de La Sabana
institution Universidad de la Sabana
bitstream.url.fl_str_mv https://intellectum.unisabana.edu.co/bitstream/10818/3418/1/Rosa%20Elena%20Salazar%20Ponce_152672.pdf
https://intellectum.unisabana.edu.co/bitstream/10818/3418/2/license.txt
https://intellectum.unisabana.edu.co/bitstream/10818/3418/3/Rosa%20Elena%20Salazar%20Ponce_152672.pdf.txt
bitstream.checksum.fl_str_mv 51fbcd039597b8325d8bbef388af1f62
f52a2cfd4df262e08e9b300d62c85cab
e19124b901adca054f8d62341e302c85
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Intellectum Universidad de la Sabana
repository.mail.fl_str_mv contactointellectum@unisabana.edu.co
_version_ 1811952223685443584
spelling Londoño Patiño, John DaríoOvalle Oñate, RafaelDe Zubiría, AlbertoBello Gualtero, Juan ManuelJaimes Fernández, Diego AlejandroSalazar Ponce, Rosa ElenaMurcia Pinilla, Lina MaríaDe la Cruz Nocera, GiovanniEspecialista en Medicina Interna2012-08-15T17:24:25Z2012-08-15T17:24:25Z20112012-08-15Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010; 39:257-68.Tikly M, Navarra SV. Lupus in the developing world is it any different? Best Pract Res Clin Rheumatol. 2008; 22:643-55.Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008; 358:929- 39.Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002; 16:847-58.McCarty DJ, Manzi S, Medsger TA, Jr., Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995; 38:1260-70.McAlindon T. Update on the epidemiology of systemic lupus erythematosus: new spins on old ideas. Curr Opin Rheumatol. 2000; 12:104-12.Simard JF, Costenbader KH. What can epidemiology tell us about systemic lupus erythematosus? Int J Clin Pract. 2007; 61:1170-80.Jimenez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003; 25:3-12.Isenberg D, Bacon P, Bombardier C, Gladman D, Goldsmith CH, Kalunian K, et al. Criteria for assessing disease activity in systemic lupus erythematosus. J Rheumatol. 1989;16:1395-6Chang E, Abrahamowicz M, Ferland D, Fortin PR. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians. J Clin Epidemiol. 2002; 55:488- 97.Gladman D, Urowitz M, Kagal A, Hallet D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheum. 2000; 27:377-9.Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005; 19:685-708.Yee CS, McElhone K, Teh LS, Gordon C. Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects. Best Pract Res Clin Rheumatol. 2009; 23:457-67.Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010; 69:1269-74.Alarcon GS, Calvo-Alen J, McGwin G, Jr., Uribe AG, Toloza SM, Roseman JM, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006; 65:1168-74.Fernandez M, Calvo-Alen J, Alarcon GS, Roseman JM, Bastian HM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. Arthritis Rheum. 2005; 52:1655-64.Gordon C, Sutcliffe N, Skan J, Stoll T, Isenberg DA. Definition and treatment of lupus flares measured by the BILAG index. Rheumatology. 2003; 42:1372-9.Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35:630-40.. Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Bombardieri S. Disease activity in systemic lupus erythematosus: report of the Consen- sus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol. 1992; 10:549-54.Gladman D, Ibanez D, Urowitz M. Systemic lupus erythematosus activity index 2000. J Rheumatol. 2002; 29:288-91.Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989; 32:1107-18.Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996; 39:363-9.Gladman DD, Urowitz MB. The SLICC/ACR damage index: progress report and experience in the field. Lupus. 1999; 8:632-7.Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus. 2001; 10:93-96.. Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response.Qual Life Res. 2001; 10:405-13Almehed K, Carlsten H, Forsblad-d'Elia H. Health-related quality of life in systemic lupus erythematosus and its association with disease and work disability. Scand J Rheumatol. 2010; 39:58-62.Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine (Baltimore). 2004; 83:1-17.Alarcón GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus. 1999; 8:197-209.Isenberg DA, Allen E, Farewell V, D'Cruz D, Alarcón GS, Aranow C, et al. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis. 2011; 70:54-9.Pope J. The revised BILAG Index with numerical scoring in systemic lupus erythematosus: added value with some limitations.Rheumatology (Oxford). 2010; 49:1616-7.Yee CS, Cresswell L, Farewell V, Rahman A, Teh LS, Griffiths B, et al. Numerical scoring for the BILAG-2004 index. Rheumatology (Oxford). 2010; 49:1665-9Furie RA, Petri MA, Wallace DJ, Ginzler EM, Merrill JT, Stohl W, et al. Novel evidencebased systemic lupus erythematosus responder index. Arthritis Rheum. 2009; 61:1143- 51.Petri M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am. 2005; 31:245-54Ruiz O, Londoño J; Velez P; Ortiz I; Motta L; Valle-Oñate R. Descripcion de una cohorte de pacientes con Lupus Eritematoso Sistemico (LES) en un Hospital de BogotaColombia. Rev Colomb Rumatol. 2003; 10:266-76.Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore). 1996; 75:124-30.Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002; 61:1065-70Garcia MA, Marcos JC, Marcos AI, Pons-Estel BA, Wojdyla D, Arturi A, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus. 2005; 14:938-46Pinto L VC, Márquez Y. Subgrupos de Lupus Eritematoso Sistémico: influencia de la edad de inicio, la raza, el sexo y el perfil de anticuerpos en las manifestaciones clínicas de la enfermedad. Rev Col Reumatol. 2008; 15:291-8Hsu CY, Pu C, Sewell KL. Systemic lupus erythematosus as a cause of failure to thrive in older people. J Am Geriatr Soc.1996; 44:337-8.Schiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, Lanzoni VP, Ferraz ML, Silva AE. Late-onset systemic lupus erythematosus-associated liver disease. Rheumatol Int. 2010 Apr 8. [Epub ahead of print]Koh ET, Boey ML. Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol. 1994; 21:1463-7.González LA, Ramírez LA. Lupus eritematoso sistémico de inicio tardío. Rev Colomb Reumatol. 2008; 15:168-85.Gaviria L, Rodelo J , Uribe O , Vásquez G, Ramírez L Características clínicas y serológicas de los pacientes con LES de inicio tardío en una población colombiana. Rev Colomb Reumatol. 2007; 14: 23-31Baer AN, Maynard JW, Shaikh F, Magder LS, Petri M. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol. 2010; 37:1143-9.Toloza SM, Jolly M, Alarcón GS. Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010; 12:237-49Drenkard C, Alarcon-Segovia D. The new prognosis of systemic lupus erythematosus: treatment-free remission and decreased mortality and morbidity. Isr Med Assoc J. 2000; 2:382-7.Duran S, Gonzalez LA, Alarcon GS. Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus erythematosus: lessons from LUMINA, a multiethnic US cohort. J Clin Rheumatol. 2007; 13:350-3Lalani S, Pope J, de Leon F, Peschken C; Members of CaNIOS/1000 Faces of Lupus. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumatol. 2010 ;37:38-44Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA. Analysis of the relationship between the disease activity and damage in patients with systemic lupus erythematosus a 5 year prospective study. Rheumatology. 2004; 43:1039-44Stoll T, Seifert B, Isenberg D. ACR/SLICC damage index is a useful predictor of severe outcome in SLE patients and an indicator of morbidity in different ethnic groups. Brit J Rheumatol. 1996; 35:248-54.Chambers SA, Allen E, Rahman A, Isenberg D. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford). 2009; 48:673-5Alarcón GS, Roseman JM, McGwin G Jr, Uribe A, Bastian HM, Fessler BJ, Baethge BA, Friedman AW, Reveille JD; LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage Rheumatology (Oxford). 2004; 43:202-5.Gilboe IM, Kvien TK, Husby G. Disease course in systemic lupus erythematosus: changes in health status, disease activity, J Rheumatol. 2001; 28:266-74Yazdany J, Yelin E. Health-Related Quality of Life and Employment Among Persons with Systemic Lupus Erythematosus . Rheum Dis Clin North Am. 2010; 36: 15–32.Alarcón GS, McGwin G Jr, Uribe A, Friedman AW, Roseman JM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004; 51:465-74.http://hdl.handle.net/10818/3418152672TE00273159 Páginas.Objetivo. Características de LES en Colombianos. Métodos. Corte transversal. Resultados. 109 pacientes; Mujeres 91.7%; Edad media diagnóstico 30,6±12,5 años. Artritis (61,5%), alopecia (59,6%) pérdida de peso (54,1%), proteinuria (34,9 %), xeroftalmia (33 %), xerostomía (28,4 %), trombocitopenia (27,5%) y S. Sjögren (21,1%) mas frecuentes. BILAG: Leve (45,9%), moderada (3,5%) y severa ( 27,5%). SLICC/ACR: 50 (45,8%). SF36: ≤50 ( 83,5% y 74,3%) y ≥51 (16,5% y 30,2%) en dominios salud física y salud mental. Correlación moderada e inversa: Estrato socioeconómico (-0,41), nivel educativo (-0,36) y daño orgánico; Correlación débil: SF 36 componente físico (-0,21) y daño orgánico. Conclusiones: Hay alta frecuencia de S. de Sjögren. Hay correlación significativa con nivel educativo, estrato socioeconómico y peor función física con daño orgánico.spaUniversidad de La SabanaEspecialización en Medicina InternaFacultad de MedicinaUniversidad de La SabanaIntellectum Repositorio Universidad de La SabanaLupus eritematoso sistémico-InvestigacionesLupus eritematoso sistémico-Epidemiología-InvestigacionesLupus eritematoso sistémico-Patología-InvestigacionesLupus eritematoso sistémico-Clases sociales-InvestigacionesCaracterísticas medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de BogotábachelorThesisTesis de especializaciónpublishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/access_right/c_abf2ORIGINALRosa Elena Salazar Ponce_152672.pdfRosa Elena Salazar Ponce_152672.pdfVer documento en PDFapplication/pdf7204908https://intellectum.unisabana.edu.co/bitstream/10818/3418/1/Rosa%20Elena%20Salazar%20Ponce_152672.pdf51fbcd039597b8325d8bbef388af1f62MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-8498https://intellectum.unisabana.edu.co/bitstream/10818/3418/2/license.txtf52a2cfd4df262e08e9b300d62c85cabMD52TEXTRosa Elena Salazar Ponce_152672.pdf.txtRosa Elena Salazar Ponce_152672.pdf.txtExtracted Texttext/plain179339https://intellectum.unisabana.edu.co/bitstream/10818/3418/3/Rosa%20Elena%20Salazar%20Ponce_152672.pdf.txte19124b901adca054f8d62341e302c85MD5310818/3418oai:intellectum.unisabana.edu.co:10818/34182019-12-18 08:34:53.766Intellectum Universidad de la Sabanacontactointellectum@unisabana.edu.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

Publicaciones similares